Cargando…

Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled Drugs

Pulmonary drug disposition after inhalation is complex involving mechanisms, such as regional drug deposition, dissolution, and mucociliary clearance. This study aimed to develop a systems pharmacology approach to mechanistically describe lung disposition in rats and thereby provide an integrated un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boger, E, Evans, N, Chappell, M, Lundqvist, A, Ewing, P, Wigenborg, A, Fridén, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834131/ https://www.ncbi.nlm.nih.gov/pubmed/27104089 http://dx.doi.org/10.1002/psp4.12074

Ejemplares similares

Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator
por: Schou, Magnus, et al.
Publicado: (2019)

Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilators
por: Hendrickx, Ramon, et al.
Publicado: (2017)

A Partial Differential Equation Approach to Inhalation Physiologically Based Pharmacokinetic Modeling
por: Boger, Elin, et al.
Publicado: (2018)

Advances in Pulmonary Drug Delivery Systems and Inhalation Formulations
por: Lam, Jenny K. W., et al.
Publicado: (2023)

Physiologically Based Pharmacokinetic Modelling of Inhaled Nemiralisib: Mechanistic Components for Pulmonary Absorption, Systemic Distribution, and Oral Absorption
por: Miller, Neil A., et al.
Publicado: (2021)

Systemic Protein Delivery via Inhalable Liposomes: Formulation and Pharmacokinetics
por: Ponkshe, Pranav, et al.
Publicado: (2023)

Receptor occupancy assessment and interpretation in terms of quantitative systems pharmacology: nivolumab case study
por: Shchelokov, Dmitry, et al.
Publicado: (2022)

Inhaled environmental/occupational irritants and allergens: mechanisms of cardiovascular and systemic responses. Introduction.
por: Yeates, D B, et al.
Publicado: (2001)

Personalizing Selection of Inhaled Delivery Systems in Chronic Obstructive Pulmonary Disease
por: Mahler, Donald A., et al.
Publicado: (2023)

Rare and new occupational inhalant allergens
por: Raulf-Heimsoth, M., et al.
Publicado: (2017)

Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats.
por: Takenaka, S, et al.
Publicado: (2001)

Effect of Smoking on the Pharmacokinetics of Inhaled Loxapine
por: Takahashi, Lori H., et al.
Publicado: (2014)

Pharmacokinetics and pharmacodynamics of moist inhalation epinephrine using a mobile inhaler
por: Breuer, C., et al.
Publicado: (2013)

Inhalation pharmacokinetics of isoprene in rats and mice.
por: Peter, H, et al.
Publicado: (1990)

An Update on Pharmacological, Pharmacokinetic Properties and Drug–Drug Interactions of Rotigotine Transdermal System in Parkinson’s Disease and Restless Legs Syndrome
por: Elshoff, Jan-Peer, et al.
Publicado: (2015)

A quantitative systems pharmacology approach, incorporating a novel liver model, for predicting pharmacokinetic drug-drug interactions
por: Cherkaoui-Rbati, Mohammed H., et al.
Publicado: (2017)

Nano-liposomal dry powder inhaler of tacrolimus: Preparation, characterization, and pulmonary pharmacokinetics
por: Chougule, Mahavir, et al.
Publicado: (2007)

Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension
por: Kuwana, Masataka, et al.
Publicado: (2023)

Fulvestrant: pharmacokinetics and pharmacology
por: Robertson, J F R, et al.
Publicado: (2004)

Biochemical study on occupational inhalation of benzene vapours in petrol station
por: Abdel Maksoud, H.A., et al.
Publicado: (2019)

Nanocrystals based pulmonary inhalation delivery system: advance and challenge
por: Yue, Pengfei, et al.
Publicado: (2022)

Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs
por: Kip, Anke E., et al.
Publicado: (2017)

Systems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of Tuberculosis
por: Cilfone, NA, et al.
Publicado: (2015)

Population Pharmacokinetics of Inhaled Fluticasone Furoate and Vilanterol in Subjects with Chronic Obstructive Pulmonary Disease
por: Siederer, Sarah, et al.
Publicado: (2015)

A mechanistic framework for a priori pharmacokinetic predictions of orally inhaled drugs
por: Hartung, Niklas, et al.
Publicado: (2020)

Quantitative Systems Pharmacology and Physiologically‐Based Pharmacokinetic Modeling With mrgsolve: A Hands‐On Tutorial
por: Elmokadem, Ahmed, et al.
Publicado: (2019)

Uncovering the regional localization of inhaled salmeterol retention in the lung
por: Bäckström, Erica, et al.
Publicado: (2018)

Identification of Pharmacokinetic Markers for Guanxin Danshen Drop Pills in Rats by Combination of Pharmacokinetics, Systems Pharmacology, and Pharmacodynamic Assays
por: Yao, Hong, et al.
Publicado: (2018)

Unraveling the pulmonary drug delivery carriers in inhalable nanostructures
por: Huang, Zhengwei, et al.
Publicado: (2022)

Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods
por: Coelho, Maria Miguel, et al.
Publicado: (2021)

Pharmacokinetic studies for proving bioequivalence of orally inhaled drug products—critical issues and concepts
por: Thakkar, Karan, et al.
Publicado: (2015)

The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis
por: Usmani, Omar S., et al.
Publicado: (2018)

Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers
por: Acosta, Maria F., et al.
Publicado: (2020)

Digestive system cancer among persons subjected to occupational inhalation of asbestos particles: a literature review with emphasis on dose response
por: Schneiderman, Marvin A.
Publicado: (1974)

Identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study
por: Shi, Peiying, et al.
Publicado: (2022)

Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers
por: de Reus, Y. A., et al.
Publicado: (2022)

Dual role of the L-arginine–ADMA–NO pathway in systemic hypoxic vasodilation and pulmonary hypoxic vasoconstriction
por: Böger, Rainer, et al.
Publicado: (2020)

Hydroxysafflor Yellow A: A Systematical Review on Botanical Resources, Physicochemical Properties, Drug Delivery System, Pharmacokinetics, and Pharmacological Effects
por: Zhao, Feng, et al.
Publicado: (2020)

Association of Occupational Exposure to Inhaled Agents in Operating Rooms With Incidence of Chronic Obstructive Pulmonary Disease Among US Female Nurses
por: Xie, Wubin, et al.
Publicado: (2021)

Inhaled Anesthetics: Environmental Role, Occupational Risk, and Clinical Use
por: Gaya da Costa, Mariana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uke5v47f9v4us134k1aeppq27e